Lenti-miR-146a-mimic suppressed the expression of Sox9 and Col2a1 in murine articular cartilage cells, whereas Lenti-miR-146a-inhibitor counteracted this effect, suggesting potential therapeutic advantages in osteoarthritis management (48). Here, SOX9 is linked to osteoarthritis.